Curcumin inhibits interferon-α induced NF-κB and COX-2 in human A549 non-small cell lung cancer cells

Jeeyun Lee, Young Hyuck Im, Hyun Jung Hae, Hyun Kim Joo, Oh Park Joon, Kihyun Kim, Seog Kim Won, Seok Ahn Jin, Won Jung Chul, Suk Park Young, Ki Kang Won, Keunchil Park

Research output: Contribution to journalArticlepeer-review

63 Scopus citations

Abstract

The A549 cells, non-small cell lung cancer cell line from human, were resistant to interferon (IFN)-α treatment. The IFN-α-treated A549 cells showed increase in protein expression levels of NF-κB and COX-2. IFN-α induced NF-κB binding activity within 30 min and this increased binding activity was markedly suppressed with inclusion of curcumin. Curcumin also inhibited IFN-α-induced COX-2 expression in A549 cells. Within 10 min, IFN-α rapidly induced the binding activity of a γ-32P-labeled consensus GAS oligonucleotide probe, which was profoundly reversed by curcumin. Taken together, IFN-α-induced activations of NF-κB and COX-2 were inhibited by the addition of curcumin in A549 cells.

Original languageEnglish
Pages (from-to)313-318
Number of pages6
JournalBiochemical and Biophysical Research Communications
Volume334
Issue number2
DOIs
StatePublished - 26 Aug 2005
Externally publishedYes

Keywords

  • Curcumin
  • Cyclooxygenase-2
  • Interferon-α
  • NF-κB
  • Non-small cell lung cancer

Fingerprint

Dive into the research topics of 'Curcumin inhibits interferon-α induced NF-κB and COX-2 in human A549 non-small cell lung cancer cells'. Together they form a unique fingerprint.

Cite this